ASYMMETRIC SYNTHESIS--STRUCTURE, STEREOCHEMISTRY AND NMR

不对称合成——结构、立体化学和核磁共振

基本信息

项目摘要

Some 270 million people worldwide are infected with malaria which causes between 1 and 2 million deaths per year. The formidable problems encountered in developing a malaria vaccine, and the ability of Plasmodium falciparum to become resistant to new drugs, has stimulated the World Health Organization and others to search for new drigs to treat this disease. Artemisinin has served as a lead compound to develop new drugs to treat the resistant strains of P. falciparum that have spread ouver southeast Asia and threaten India and Aftica. Since no strains P. falciparum resistant to artemisinin derivatives have appeared, many derivatives (esters and ethers of dihydtoartemisinin) have been prepared in China and the United States. Metabolic studies of arteether, a dihydroartemisinin derivative scheduled for clinical tests, found that it is rapidly dealkylated to dihydroartemisinin. It is very likely that esters of dihydroartemisinin are rapidly hydrolyzed to the same compound. In order to prepare compounds that can not be degraded to dihydroartemisinin, we introduced additional functional groups into artemisinin by a microbially mediated oxidation using Beauveria sulfurescens. Derivatives of these hydroxylated materials hiave been prepared and tested. IN a second approach we replaced by hydroxy group of dihydroartemisinin with an allyl group. The double bond of the allyl substitutent enabled us to introduce polar groups into the molecule so as to adjust its lipo- or hydro-philicity. The polarity is important in deciding the mode of administration. Most of the compounds were found to be as or more effective than artemisinin and arteether against P. falciparum in vitro. The best compound, the n-propyl derivative, is undergoing in vivo testing in mice infected with P. berghei.
全世界约有2.7亿人感染疟疾

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

H ZIFFER其他文献

H ZIFFER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('H ZIFFER', 18)}}的其他基金

ASYMMETRIC SYNTHESIS--STRUCTURE, STEREOCHEMISTRY AND NMR
不对称合成——结构、立体化学和核磁共振
  • 批准号:
    5201943
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ASYMMETRIC SYNTHESIS--STRUCTURE, STEREOCHEMISTRY AND NMR
不对称合成——结构、立体化学和核磁共振
  • 批准号:
    3776276
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ASYMMETRIC SYNTHESIS--STRUCTURE, STEREOCHEMISTRY AND NMR
不对称合成——结构、立体化学和核磁共振
  • 批准号:
    4689595
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ASYMMETRIC SYNTHESIS--STRUCTURE, STEREOCHEMISTRY AND NMR
不对称合成——结构、立体化学和核磁共振
  • 批准号:
    3754167
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ASYMMETRIC SYNTHESIS--STRUCTURE, STEREOCHEMISTRY AND NMR
不对称合成——结构、立体化学和核磁共振
  • 批准号:
    3964446
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ASYMMETRIC SYNTHESIS--STRUCTURE, STEREOCHEMISTRY AND NMR
不对称合成——结构、立体化学和核磁共振
  • 批准号:
    3875833
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ASYMMETRIC SYNTHESIS--STRUCTURE, STEREOCHEMISTRY AND NMR
不对称合成——结构、立体化学和核磁共振
  • 批准号:
    3917716
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ASYMMETRIC SYNTHESIS--STRUCTURE, STEREOCHEMISTRY AND NMR
不对称合成——结构、立体化学和核磁共振
  • 批准号:
    3854783
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ASYMMETRIC SYNTHESIS--STRUCTURE, STEREOCHEMISTRY AND NMR
不对称合成——结构、立体化学和核磁共振
  • 批准号:
    6161927
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ASYMMETRIC SYNTHESIS--STRUCTURE, STEREOCHEMISTRY AND NMR
不对称合成——结构、立体化学和核磁共振
  • 批准号:
    3940611
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Investigation of the molecular mechanism of RON4 in Plasmodium berghei sporozoite infection of mammalian hosts
RON4在伯氏疟原虫子孢子感染哺乳动物宿主中的分子机制研究
  • 批准号:
    20K16235
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Role of IFNGR1 in pregnant mice infected with Plasmodium berghei
IFNGR1 在感染伯氏疟原虫的怀孕小鼠中的作用
  • 批准号:
    15K08451
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Suppression of experimental cerebral malaria by activation of nonlethal malaria parasite-specific CD4+T cells via MHC class II in mice coinfected with Plasmodium berghei ANKA and nonlethal Pb XAT
在伯氏疟原虫 ANKA 和非致命性 Pb XAT 共感染的小鼠中,通过 MHC II 类激活非致命性疟疾寄生虫特异性 CD4 T 细胞来抑制实验性脑型疟疾
  • 批准号:
    24790405
  • 财政年份:
    2012
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
The suppression of severe pathology during coinfection with Plasmodium berghei ANKA and Plasmodium berghei XAT
伯氏疟原虫 ANKA 和伯氏疟原虫 XAT 共感染期间严重病理的抑制
  • 批准号:
    21790410
  • 财政年份:
    2009
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
The impact of multiple stresses including infection with Plasmodium berghei on mosquito behaviour
包括伯氏疟原虫感染在内的多种应激对蚊子行为的影响
  • 批准号:
    303583-2005
  • 财政年份:
    2005
  • 资助金额:
    --
  • 项目类别:
    Postgraduate Scholarships - Master's
Wechselseitige Beeinflussung der Infektionsverläufe von muriner Malaria und Nematodeninfektion am Beispiel der Co-Infektion von Plasmodium berghei mit Litomosoides sigmodontis bzw. Nippostrongylus brasiliensis
以伯氏疟原虫与乙状疟原虫和巴西圆线虫共同感染为例探讨鼠疟疾和线虫感染过程的相互影响
  • 批准号:
    5423379
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Comparison of the Plasmodium berghei Multi-drug Resistance Associated Protein (
伯氏疟原虫多重耐药相关蛋白的比较(
  • 批准号:
    6980095
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:
Survival strategies of Plasmodium berghei exoerythrocytic forms (EEF) in hepatocytes
伯氏疟原虫红细胞外型(EEF)在肝细胞中的生存策略
  • 批准号:
    5435108
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:
    Priority Programmes
The impact of multiple stresses including infection with Plasmodium berghei on mosquito behaviour
包括伯氏疟原虫感染在内的多种应激对蚊子行为的影响
  • 批准号:
    303583-2004
  • 财政年份:
    2004
  • 资助金额:
    --
  • 项目类别:
    Postgraduate Scholarships - Master's
Characterization of newly defined protective antigens of Plasmodium berghei XAT.
新定义的伯氏疟原虫 XAT 保护性抗原的表征。
  • 批准号:
    14570219
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了